MNTA - Momenta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue-138,882109,61989,650
Cost of Revenue-72,46741,17352,585
Gross Profit-66,41568,44637,065
Operating Expenses
Research Development-76,75978,70773,448
Selling General and Administrative-82,20764,46648,051
Non Recurring----
Total Operating Expenses-231,433184,346174,084
Operating Income or Loss--92,551-74,727-84,434
Income from Continuing Operations
Total Other Income/Expenses Net-4,45553,7241,121
Earnings Before Interest and Taxes--92,551-74,727-84,434
Interest Expense----
Income Before Tax--88,096-21,003-83,313
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--88,096-21,003-83,313
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--88,096-21,003-83,313
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--88,096-21,003-83,313